Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Single vs Dual Trigger in Poor Responders for ICSI
NCT04008966Phase 4Completed
- Sponsor
- Cairo University
- Start
- Jul 2016
- Primary completion
- Jun 2019
- Modality
- Peptides, Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of triptorelin in poor ovarian response (POR) (2 arms), sponsored by Cairo University. Primary endpoint: number of mature follicular count. Started Jul 2016; status: completed.
02
Drugs
triptorelin
03
Conditions
poor ovarian response (POR)
Beyond the preview
Go deeper on NCT04008966.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04008966.